Brief: Oncoarendi Therapeutics Q1 Net Loss Widens To 0.6 Mln Zlotys
30/05/2018 07:17
May 30 (Reuters) - ONCOARENDI THERAPEUTICS SA OAT.WA :
* Q1 NET LOSS OF 0.6 MILLION ZLOTYS VERSUS LOSS OF 0.5
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING REVENUE 0.4 MILLION ZLOTYS VERSUS 0.2 MILLION
ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM5Jtl6Na
Further company coverage: OAT.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Molecure SA
See all newsBrief: Molecure Q1 Net Loss 4.1 Mln Zlotys
Brief: Molecure Says Its In-Consortium Project Selected For Funding By Medical Research Agency
Brief: Molecure To Sell 4.12 Mln Series K Shares and 2.0 Mln Existing Shares At 5 Zlotys/Shr
Brief: Molecure Starts ABB For Up to 4.12 Mln New Series K Shares And Up To 2.0 Mln Existing Shares
Brief: Molecure Signs Conditional Investment Agreement With MS Galleon And Szumowski Investments